Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Direct Meds vs Healthicare

Direct Meds
Graded #19

Higher grade

vs+17.099999999999994
Healthicare
Graded #221

Lower grade

The verdict

Direct Meds takes it — 82.6/100 to 65.5/100.

Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDirect Meds +27
85
58
Dose & formulationEven
88
88
Clinical oversightDirect Meds +9
80
71
Labs & monitoringDirect Meds +25
78
53
FulfillmentDirect Meds +18
80
62
Contract termsDirect Meds +33
80
47
Direct Meds · left barHealthicare · right bar

The numbers

MetricDirect MedsHealthicare
WeighScore82.6/10065.5/100
GradeB−C
Scorecard rank#19#221
Semaglutide$179/mo$174/mo (compounded)
Tirzepatide$224/mo$264/mo (compounded)
CoverageNot publicly listedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
Direct Meds

Graded #19 · B−

Strengths

  • Rare oral/sublingual option in addition to injectable
  • All-inclusive pricing with no separate membership fee
  • Both molecules — semaglutide and tirzepatide
  • Intro promotional pricing near $147

Where it loses points

  • Compounded only — not FDA-approved
  • Pricing is company-stated, not independently live-verified
  • Newer and somewhat ambiguous (operates across multiple domains)
  • States served are not disclosed
Healthicare

Graded #221 · C

Strengths

  • Both compounded and full brand-name menu (Ozempic, Wegovy, Mounjaro, Zepbound) on one platform
  • Pharmacy partner named publicly: Jungle Jim's Pharmacy (F&F Pharmacies Inc.), Fairfield, OH
  • Clinical lead named publicly: Dr. Jonah Mink, Beluga Health
  • Compounded semaglutide from $147.90/mo on the 3-month plan ($174/mo billed monthly) — lower end of the segment

Where it loses points

  • Not available in several states including CA, NV, NJ, NC, TX, MA — verify your state first
  • Brand-name first-month pricing of $1,199.99–$1,299.99 is at or above cash retail; value is on the compounded tier
  • Footer references 'Sunshine Health Studios Inc.' — relationship to the domain owner is unclear

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard